PIN-G – A novel reporter for imaging and defining the effects of trafficking signals in membrane proteins by McKeown, Lynn et al.
BioMed  Central
Page 1 of 11
(page number not for citation purposes)
BMC Biotechnology
Open Access Methodology article
PIN-G – A novel reporter for imaging and defining the effects of 
trafficking signals in membrane proteins
Lynn McKeown, Philip Robinson, Sam M Greenwood, Weiwen Hu and 
Owen T Jones*
Address: Faculty of Life Sciences, University of Manchester. 1.136 Stopford Building, Oxford Road, Manchester, M13 9PT, UK
Email: Lynn McKeown - lynn.mckeown@manchester.ac.uk; Philip Robinson - p.robinson-2@student.manchester.ac.uk; 
Sam M Greenwood - s.m.greenwood@dundee.ac.uk; Weiwen Hu - weiwen.hu@hotmail.com; Owen T Jones* - owen.t.jones@manchester.ac.uk
* Corresponding author    
Abstract
Background: The identification of protein trafficking signals, and their interacting mechanisms, is
a fundamental objective of modern biology. Unfortunately, the analysis of trafficking signals is
complicated by their topography, hierarchical nature and regulation. Powerful strategies to test
candidate motifs include their ability to direct simpler reporter proteins, to which they are fused,
to the appropriate cellular compartment. However, present reporters are limited by their
endogenous expression, paucity of cloning sites, and difficult detection in live cells.
Results: Consequently, we have engineered a mammalian expression vector encoding a novel
trafficking reporter – pIN-G – consisting of a simple, type I integral protein bearing permissive intra/
extracellular cloning sites, green fluorescent protein (GFP), cMyc and HA epitope tags.
Fluorescence imaging, flow cytometry and biochemical assays of transfected HEK293 cells, confirm
the size, topology and surface expression of PIN-G. Moreover, a pIN-G fusion construct, containing
a Trans-Golgi Network (TGN) targeting determinant, internalises rapidly from the cell surface and
localises to the TGN. Additionally, another PIN-G fusion protein and its mutants reveal trafficking
determinants in the cytoplasmic carboxy terminus of Kv1.4 voltage-gated potassium channels.
Conclusion: Together, these data indicate that pIN-G is a versatile, powerful, new reporter for
analysing signals controlling membrane protein trafficking, surface expression and dynamics.
Background
The identification of sequence motifs that direct proteins
to appropriate intracellular and plasma membrane locales
represents a fundamental objective of cell biology [1].
Once defined, such signals permit the identification of
mechanisms underlying protein trafficking [2] and the
targeted delivery of therapeutic agents to those subcellular
domains where they are most effective [3]. Unfortunately,
the identification of trafficking signals is not trivial as they
may consist of non-contiguous amino acids, whose juxta-
position to form a binding site may only be apparent in
the fully folded protein [4]. Even in cases where trafficking
signals are comprised of contiguous amino acids, they
may be hard to identify since they lie within discrete sub-
units of complex oligomeric proteins [5]. Moreover, traf-
ficking signals may overlap [6], act hierarchically [7], or be
capable of being switched from inactive to active states
through second messenger regulation [8].
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A well-established strategy to identify trafficking signals
has been to infer their necessity and sufficiency from their
ability to direct simpler reporter proteins to which they are
fused, to the appropriate cellular compartment [9-11].
Unfortunately, available reporter proteins have numerous
limitations including their endogenous expression in
diverse cells and tissues, lack of convenient cloning sites
and potential interactions with intra- or extracellular pro-
teins that may affect their subcellular distributions [12].
Even more significant is the limited capacity for detection
of presently available reporters, not least because of their
reliance upon the limited range of antibodies that are
commercially available and the indirect nature of the
detection methodology. To circumvent such problems, we
have engineered an alternative protein trafficking reporter
system (Fig. 1) consisting of a simple artificial type I inte-
gral protein bearing permissive intra- and extracellular
multiple cloning sites, a green fluorescent protein moiety
(GFP) that permits direct localisation by fluorescence
imaging in live cells and epitope tags for biochemical
detection of protein turnover and surface expression.
Results
Vector construction
To generate a suitable trafficking reporter (Fig. 1), a region
encoding EGFP and unique extracellular restriction sites
from pEGFP-C1 (Clontech) was first inserted into the cell
surface expression vector, pDisplay, (Invitrogen) to gener-
ate an intermediate EGFP-pDisplay construct (Fig. 1A).
The entire protein coding region of EGFP-pDisplay was
then PCR amplified and cloned into a pEGFP backbone
lacking the EGFP insert, thereby introducing a second, dis-
tinct, intracellular multiple cloning site (MCS-2). The pri-
mary homologue, described henceforth as pIN-G, is a
Cloning scheme for the preparation of the pIN-G construct and the transmembrane topology of the pIN-G reporter protein Figure 1
Cloning scheme for the preparation of the pIN-G construct and the transmembrane topology of the pIN-G reporter protein. 
1A. A fragment encoding EGFP, obtained by AgeI/SalI digestion of pEGFP-C1, was ligated into an XmaI/SalI digested pDisplay 
backbone and the entire protein coding region PCR-amplified and ligated into a host backbone generated through NheI/KpnI 
digestion of pEGFP-C1 to retain the 3' multiple cloning site but exclude the EGFP coding region. The final pIN-G construct, 
with the appropriate reading frame throughout, was generated via a subsequent round of PCR. See Methods for further details. 
1B. Following expression and cleavage of the Igk- chain leader sequence, the pIN-G protein is proposed to adopt a transmem-
brane orientation where HA and cMyc epitope tags and GFP have an extracellular disposition at the cell surface (or intra-lume-
nal in organelles or vesicular trafficking intermediates).
EGFP
Age I Sal I
Xma I Sal I
Nhe I Kpn I
EGFP
TM Domain
Age I Sal I
pEGFP-C1
Kpn I Nhe I
Nhe I Kpn I
Xma I
pDisplay
Sal I
PCR
Nhe I/Kpn I Age I/Sal I Xma I/Sal I
MCS-2
cMyc tag HA tag EGFP
Igk-Leader
MCS-1
pIN-G
(5042bp)
Kanr
hCMV
pUCori
SV40 poly A
EGFP
Age I Sal I
Xma I Sal I
Nhe I Kpn I
EGFP
TM Domain
Age I Sal I
pEGFP-C1
Kpn I Nhe I
Nhe I Kpn I
Xma I
pDisplay
Sal I
PCR
Nhe I/Kpn I Age I/Sal I Xma I/Sal I
MCS-2
cMyc tag HA tag EGFP
Igk-Leader
MCS-1
pIN-G
(5042bp)
Kanr
hCMV
pUCori
SV40 poly A
N-terminus
C-terminus
MCS-1
MCS-2
HA tag
cMyc tag 
Cytoplasm
TM Domain
(PDGFR)
N-
EGFP
ABBMC Biotechnology 2006, 6:15 http://www.biomedcentral.com/1472-6750/6/15
Page 3 of 11
(page number not for citation purposes)
5042bp pUC-based vector (see Table 1 for details) con-
taining all the desired protein coding elements in the cor-
rect reading frame (Fig. 1B)(deposited in Genbank as
Accession number AY841887).
Properties of pIN-G
Transfection of pIN-G into HEK293 cells, and subsequent
immunoblotting with antibodies against EGFP and HA
disclosed a novel 41.3 kDa band, which was absent from
mock-transfected cells (Fig. 2a). Constructs encoding pIN-
G fused to a TGN targeting motif and the carboxy termi-
nus of the voltage-gated potassium channel Kv1.4 gave
bands of (44 kDa) and (51 kDa), respectively.
Fluorescence images of pIN-G-transfected HEK293 cells
(Fig. 2b panel A) revealed strong green heterogeneous flu-
orescence within intracellular organellar structures and at
the plasma membrane. In contrast, EGFP alone (Fig. 2b
panel B) was expressed homogeneously throughout the
cell. Thus, the presence of an Igκ leader sequence and the
PDGF receptor transmembrane region, but no added traf-
ficking motifs, appeared to direct pIN-G via the secretory
pathway to the cell surface. To confirm this, first, the sur-
face expression of pIN-G was tested by immunostaining
non-permeabilized fixed cells with anti-EGFP (Fig. 2b
panels D-F) and anti-HA (Fig. 2b panels G-I), and subse-
quent detection with Cy3-labeled secondary antibodies.
In each case, Cy-3 (red) fluorescence overlapped strongly
with pIN-G fluorescence at the cell margin, and was
absent upon omission of primary antibody to mock-trans-
fected cells (Fig. 2b panel C). Next, the intracellular dispo-
sition of pIN-G was resolved through
immunocytochemistry with established antibody markers
(in parentheses) to membranous organelles (Fig. 3A–D)
including (A) the Golgi apparatus (GM130) [16], (B)
early endosomes (EAA-1) [17], (C) the endoplasmic retic-
ulum (ER; calnexin) [18] and (D) the lysosomes (LAMP-
1)[19]. Throughout, we found no evidence for cytotoxic-
ity or inclusion body formation.
pIN-G is a faithful trafficking reporter
Next, we sought to establish the potential of pIN-G as a
reporter of protein trafficking by exploiting the observa-
tion that a contiguous carboxy terminal motif within
TGN-38 is both necessary and sufficient to localise this
protein to the Trans-Golgi Network (TGN)[20]. Thus,
cDNA encoding the TGN-38 signal with a corresponding
stop codon, was cloned into the putative intracellular
multiple cloning site of pIN-G (MCS-2) to yield a con-
struct, designated as pIN-TGN. Fluorescence imaging of
Table 1: Features of the pIN-G reporter system. Features of the pIN-G Trafficking Reporter Plasmid. Nucleotide positions of the 
corresponding features of pIN-G are indicated in the right hand column. Unique restriction sites for the extracellular and intracellular 
Multiple Cloning Sites (MCS-1 and MCS-2, respectively) are italicised. Asterisks denote enzymes yielding blunt ends.
Feature Position (bp)
Human CMV promoter 1–589
Enhancer region 59–465
AP1 binding site 400–407
CAAT box 521–525
TATA box 554–560
Transcription start site 583
Kozak translation initiation site 606–612
pIN-G start codon 613–615
Igκ-chain leader sequence 613–675
Haemagglutinin epitope tag 676–702
Unique Pvu I site 708
Enhanced Green Fluorescent Protein (EGFP) 742–1458
MCS-1 (BsrGI,AccIII,XhoI,Ecl136I*,SacI,HindIII,EcoRI,PstI,SalI) 1451–1504
c-Myc epitope tag 1504–1533
PDGFR transmembrane domain 1537–1685
MCS-2 (KpnI, SacII,ApaI, SmaI*,BamHI,XbaI,BclI) 1686–1718
pIN-G stop codon 1723–1725
SV40 early mRNA polyadenylation signals 1861–1866,1890–1895
mRNA ends 1899,1911
F1 single-strand DNA origin 1958–2413
Kanr bacterial promoter 2475–2480,2498–2503
Kanr transcription start point 2510
SV40 early promoter (tandem 72 bp) 2587–2730
SV40 origin of replication 2754–2889
Kanamycin/neomycin resistance gene 2938–3732
Herpes simplex thymidine kinase poly-A signal 3968–3973,3981–3986
pUC plasmid origin of replication 4317–4960BMC Biotechnology 2006, 6:15 http://www.biomedcentral.com/1472-6750/6/15
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a) pIN-G and fusion protein constructs yield proteins of the anticipated sizes following expression in HEK293 cells Figure 2
a) pIN-G and fusion protein constructs yield proteins of the anticipated sizes following expression in HEK293 cells. Detection 
of pIN-G protein (lane 2) through immunoblotting (see Methods) with antibodies against HA and GFP reveals a protein of 41 
kDA. Lanes 3 and 4 correspond to pIN-G fusion proteins bearing the carboxy terminus of the Kv1.4 potassium channel (pIN-
JHE811) or TGN38 trans-Golgi Network targeting motif (pIN-TGN38), respectively. Lane 1 corresponds to mock-transfected 
cells. b) Total and surface expression of pIN-G in transfected HEK293 cells determined through fluorescence imaging. HEK293 
cells transiently transfected with pIN-G (A) or EGFP (B) were fixed and viewed with a 100× objective using a DeltaVision 
workstation (Methods) (Panel C denotes background fluorescence of mock-transfected cells upon omission of primary anti-
body). Panels D-I, denote total (D and G) versus surface (E and H) expression of pIN-G determined through treatment of non-
permeabilised pIN-G-transfected cells with antibodies to EGFP (E), and HA (H), followed by fixation and labeling with the 
appropriate Cy3-conjugated secondary antibody. Panels F and I indicate merged images. Green: pIN-G fluorescence; blue: 
DAPI (nuclei); red Cy3 2° antibody. Areas of red/green overlap are shown in yellow. Scale bars correspond to 15 µM.
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HEK293 cells transfected with pIN-TGN (Fig. 4), revealed
a high concentration of fluorescence in vesicles and mem-
branes distributed proximal to the nucleus in a character-
istic 'signet ring' pattern (Fig. 4B) distinct from that seen
with either pIN-G (Fig. 3A–D and Fig. 4A) or EGFP (Fig.
2b panel B). Further immunocytochemistry showed
extensive co-localisation of pIN-TGN with the Golgi appa-
ratus, but not markers of early endosomes, the ER or lyso-
somes (Fig 4C–F, respectively).
Analysis of pIN-G surface expression levels
To confirm the cell surface disposition of pIN-G and pIN-
fusion constructs, and its facile resolution by cell sorting
assays, FACS analysis was used. In mock-transfected cells
(Fig. 5A), or those treated with Cy5 secondary antibodies
alone (Fig. 5B), most cells showed low fluorescence (Fig.
4, quadrant R3 (red) and R6 (green)). However, upon
transfection with pIN-G or pIN-TGN, a new population of
cells was revealed that showed strong fluorescence in the
green channel, (Fig. 5C, 5D, quadrant R6). After surface
labelingof pIN-G and pIN-TGN transfected cells, with
anti-HA and Cy5 primary and secondary antibodies, a
novel cell population displaying both red and green fluo-
rescence (Fig. 5E and 5F, quadrant R4) emerged, corre-
sponding to those expressing construct at the cell surface.
By defining F as the fraction of transfected cells in the R4
quadrant (i.e. F = R4/(R4+R6)), pIN-G surface expression
was much greater than that of pIN-TGN (F = 0.99 vs. 0.44,
respectively).
A pIN-G fusion protein identifies internalization 
determinants in the Kv1.4 carboxy terminus
Available evidence suggests that Kv1 family potassium
channels contain one or more carboxy terminal internali-
zation determinants [15,21]. To identify such determi-
nants, a construct was generated encoding pIN-G to which
the entire carboxy terminus of rat Kv1.4 (Genbank acces-
sion no. NM 012971) had been fused (pIN-JHE811). In
transfected HEK293 cells, pIN-JHE811 fluorescence was
localized to intracellular membrane vesicles and the cell
surface (Fig. 6a, panel A). Surface expression of pIN-
JHE811 was confirmed through immunocytochemistry of
non-permeabilised cells treated at 4°C with antibodies
raised against the HA epitope tag (see Fig. 6a, panel B).
However, in contrast to pIN-G (Fig. 6b, panel C), pIN-
JHE811 surface labeling appeared less intense as indicated
by a decrease in green:red (yellow) surface staining (Fig.
6b, panel E). Since, pIN-JHE811 contains putative inter-
nalization motifs, we questioned whether such dimin-
ished surface labeling at steady-state compared to pIN-G,
might reflect partial redistribution of pIN-JHE811 into the
endocytic pathway. To test this notion, we determined the
fate of surface-labeled pIN-JHE811 compared to pIN-G
following a pulse chase-protocol with anti-HA antibody
(Fig. 6b panels C-F). After 1 h of internalization prior to
labeling with Cy3-conjugated secondary antibodies (see
Methods), cells expressing pIN-JHE811 showed dimin-
ished surface labeling compared to cells fixed and labeled
immediately after anti-HA application i.e. at time 0 h
(Figs. 6b panels E, F). In contrast, a similar high level of
surface labeling was seen at both t = 0 h and 1 h for cells
expressing pIN-G (Figs. 6b panels C, D). Since TGN-38 is
routed via the surface to the TGN [13,14], we also tested
internalization of anti-HA in cells expressing pIN-TGN. As
shown in Figs. 6b panels G and H, surface labeling of pIN-
TGN, while weak at t = 0 h, was negligible after 1 h.
Inspection of the C-terminal sequence of Kv1.4 reveals the
presence of several candidate internalization motifs
(notably di-leucine Leu-594/Leu-595 and Tyr-612). In
anti-HA pulse-chase experiments, a di-leucine mutant,
Leu594Ala (pIN-JHE811 L-A), surprisingly, showed
enhanced intracellular and diminished cell surface Cy3-
labeling compared to pIN-JHE811 (Fig. 6b panels I and J).
In contrast, a Tyr612-Phe (pIN-JHE811 Y-F) mutant
showed enhanced surface and reduced intracellular labe-
Intracellular distribution of PIN-G in membrane compart- ments Figure 3
Intracellular distribution of PIN-G in membrane compart-
ments. HEK293 cells transiently transfected with pIN-G, 
were fixed, permeabilised and treated with antibodies (See 
Methods) to the following organelle markers: A, GM130 
(Golgi apparatus); B, EEA1 (Early endosomes); C, Calnexin 
(Endoplasmic Reticulum) and D, LAMP-1 (Lysosomes) fol-
lowed by appropriate Cy-3 conjugated secondary antibody. 
Green denotes pIN-G fluorescence while red corresponds 
to the organelle marker. Areas of red/green overlap are 
shown in yellow. Blue indicates DAPI-stained nuclei. Scale 
Bar: 15 µM.BMC Biotechnology 2006, 6:15 http://www.biomedcentral.com/1472-6750/6/15
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ling (Fig. 6b panels K and L). FACS analysis of cells
expressing pIN-JHE811 mutants at t = 0 and 1 hr yielded
internalization half-lives commensurate with the imaging
data of 160mins, 40 mins and infinity for pIN-JHE811; L-
A and Y-F, respectively. Thus, like the homologous residue
(position 457) in Kv1.2, tyrosine 612 serves as a critical
internalization signal [21].
Discussion
In this paper, we describe a novel construct – pIN-G – for
the facile detection of trafficking determinants within
membrane proteins. Expression of pIN-G yields an artifi-
cial, GFP-tagged, protein – PIN-G – whose characteristics
and topology conform to the type I protein depicted in
Figure 1B. Thus, PIN-G is recognised by surface-applied
antibodies corresponding to each extracellular moiety and
is also re-distributed by sequences appended to the puta-
tive intracellular domain. The presence of PIN-G at the
cell surface (and throughout membranes of the secretory
pathway) also suggests that it does not contain any intrin-
sic targeting or trafficking determinants. However, the
addition of sequences containing known or putative tar-
geting determinants re-specifies the trafficking fate of the
expressed fusion construct indicating that pIN-G is a faith-
ful reporter for visualising and analysing trafficking mech-
anisms. Equally salient is the utility of the pIN-G system
in identifying and dissecting motifs, such as the previ-
ously undocumented Tyr612 in Kv1.4, that control the
dynamics and expression of cell surface proteins, espe-
cially when, like Kv1.4, they have no specific radioactive
ligands or where biotinylation strategies may not be
straightforward.
In contrast to existing reporters [9-11], the pIN vector is a
considerably more versatile tool, not least because of the
presence of intra- and extracellular multiple cloning sites,
epitope and GFP tags and lack of endogenous expression.
Moreover, unlike with present reporters, any aberrant
expression of pIN-G or its fusion constructs (such as inclu-
sion body formation), while absent in the present study,
should be readily visualised. Such versatility could be
extended even further to include the dynamic visualisa-
tion of interacting proteins in live cells [22], and the
development of combinatorial library approaches for
identifying intracellular or extracellular signalling mecha-
nisms affecting trafficking [23]. Other potential applica-
tions of pIN technology include the generation of
constructs with alternate fluorophores to GFP such as
mRFP [24], thereby, permitting the development of bio-
sensors or energy transfer assays between pIN-fusion con-
structs. Finally, the reasonably small size and simplicity of
the pIN construct, especially when compared to most
integral proteins mediating signal transduction, should
facilitate the analysis of trafficking in cells such as neurons
which are hard to transfect [25] and also the development
of viral gene delivery methodologies where packaging size
is critical [26].
Conclusion
Here we have described the construction and faithful
expression of a novel trafficking reporter protein, specifi-
cally designed for the detection and characterization of
autonomous trafficking motifs. By incorporating epitope
Re-specification of the distribution of pIN-G by an autono- mous targeting signal Figure 4
Re-specification of the distribution of pIN-G by an autono-
mous targeting signal. HEK293 cells transiently transfected 
with pIN-G or pIN-TGN38 – a fusion construct correspond-
ing to pIN-G bearing the autonomous targeting signal of the 
Trans-Golgi Network resident protein TGN-38 – were 
fixed, stained and imaged on a Delta-Vision workstation. 
Panel A, pIN-G; Panel B, pIN-TGN. HEK293 cells transiently 
transfected with pIN-TGN38, were fixed, permeabilised and 
treated with antibodies (See Methods) to the following 
organelle markers: C, GM130 (Golgi apparatus); D, EEA1 
(early endosomes); E, Calnexin (endoplasmic reticulum) and 
F, lamp-1 (Lysosomes) followed by the appropriate Cy-3 
conjugated secondary antibody. Green denotes pIN fluores-
cence while red corresponds to the organelle marker. Areas 
of red/green overlap are shown in yellow. Blue indicates 
DAPI-stained nuclei. Scale Bar: 15 µM.BMC Biotechnology 2006, 6:15 http://www.biomedcentral.com/1472-6750/6/15
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and GFP tags into a simple type I transmembrane protein,
our construct permits the direct visualization and bio-
chemical dissection of protein signals and signalling
domains transplanted from much more complex parent
membrane proteins. The potential uses of the pIN-G
reporter are, however, not limited to trafficking studies
and could serve as a platform for the development of
novel biosensors and the high-throughput screening of
protein-protein interactions.
Methods
Materials
A clone encoding GFP- tagged TGN-38 (p∆Mep4-TGN-38-
GFP) was a gift from Dr. G. Banting, (Univ. Bristol, UK).
Monoclonal antibodies GM130, anti-EEA-1 and anti-cal-
nexin were purchased from BD Biosciences Pharmingen,
Oxford, U.K. and anti-HA.11 from Covance Research
Products, Berkeley, U.S.A. The 9E10 anti-cMyc antibody
was a gift from Prof. M. Humphries lab (Manchester,
U.K.) and anti-TGN46 a gift from Dr. M. Lowe (Manches-
ter, U.K.). The Lamp-1 antibody (clone H4A3) developed
by August and Hildreth was obtained from the Develop-
mental Studies Hybridoma Bank, Iowa, U.S.A. Polyclonal
antibodies raised against GFP (A11122) were obtained
from Molecular Probes, Invitrogen, Paisley, U.K. Immu-
noblotting reagents were from Amersham Pharmacia Bio-
tech, Bucks, U.K. Oligonucleotides were synthesized by
ACGT Inc., Toronto, ON, Canada or Sigma-Genosys, U.K.
All other chemicals were of reagent grade or higher purity.
pIN-G vector construction
Generation of the pIN-G construct (Fig. 1B) was achieved
by first digesting the pEGFP-C1 vector (Clontech, Palo
Alto, CA) with Age I (bp 601) and Sal I (bp 1370) to yield
a 769 bp fragment, corresponding to the coding region of
EGFP. The resulting fragment was then subcloned into the
Xma I (bp 849) and Sal I (bp 869) sites of the pDisplay
vector (Invitrogen, San Diego, CA) to give a 6074 bp inter-
mediate EGFP-pDisplay construct. The entire protein cod-
ing region of EGFP-pDisplay (bp732–1803) was then
subject to PCR amplification using the following forward
and reverse oligonucleotide primers: 5'-ATC CGC TAG
CGC TAC TAG TCG CCA CCA TGG AGA CAG ACA CAC
TC-3' and 5'-AAA GAC CGG TGA ACG TGG CTT CTT CTG
CCA AAG CAT-3' which also served to introduce Nhe I
and Kpn I sites for subcloning. Separately, the entire
EGFP-coding region was excised from pEGFP-C1 by diges-
tion with Nhe I (bp592) and Kpn I (bp1380). The linear-
ized pEGFP-C1 backbone was then used as a host into
which the EGFP-pDisplay PCR fragment, generated
above, was subcloned. The resulting 5037 bp pIN precur-
sor construct (pIN-G') was then used to generate pIN con-
struct derivatives. For example, pIN-G was constructed by
generating two PCR fragments pIN-A (401 bp), contain-
ing SnaB I and Pvu I sites for subcloning, (forward primer:
5'-GGA CTT TCC TAC TTG GCA GTA C-3'; reverse primer:
5'-TTT TCG ATC GCA GCA TAA TCT GGA ACA TCA TAT
GG-3') and pIN-B (996 bp), containing Pvu I and Kpn I
sites for subcloning, (forward primer: 5'-AAA ACG ATC
GAA CCC AGC CGG CCA GAT CT-3'; reverse primer: 5'-
AAA GGG TAC CGA ACG TCG CTT CTT CTG CCA AAG
CAT-3') from the pIN-G' template. Fragments pIN-A and
Differences in the surface levels of pIN-fusion proteins deter- mined by flow cytometry Figure 5
Differences in the surface levels of pIN-fusion proteins deter-
mined by flow cytometry. HEK293 cells transfected with no 
cDNA (mock, panel A and B), pIN-G (panel C and E) or pIN-
TGN (panel D and F) were subjected to FACS analysis either 
with (panel B, E and F) or without (panel A, C and D) anti-
HA antibody followed by detection with Cy5-conjugated 
goat anti-mouse IgG1 (Methods). Calculated mean fluores-
cent intensity (MFI) values determined the background fluo-
rescence (panel A) and non-specific antibody binding (panel 
B) of mock transfected cells. Panel C and D demonstrate the 
specific GFP fluorescence of pIN-G or pIN-TGN transfected 
cells respectively (quadrant R5), whilst surface labeling of 
transfected cells, with anti-HA and Cy5 primary and second-
ary antibodies reveal a cell population displaying both red and 
green fluorescence (panels E and F, quadrant R4).BMC Biotechnology 2006, 6:15 http://www.biomedcentral.com/1472-6750/6/15
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a) Total versus surface expression of pIN-JHE811 – a fusion construct corresponding to pIN-G bearing the cytoplasmic car- boxy terminus of Kv1 Figure 6
a) Total versus surface expression of pIN-JHE811 – a fusion construct corresponding to pIN-G bearing the cytoplasmic car-
boxy terminus of Kv1.4. HEK293 cells transiently transfected with pIN-JHE811 were fixed, stained and imaged on a Delta-
Vision workstation. Panel A demonstrates total cellular pIN-JHE811 fluorescence (green) whilst panel B depicts surface staining 
of pIN-JHE811 with anti-HA antibodies (red: as described in Methods). Blue indicates DAPI-stained nuclei. b) Site-directed 
mutagenesis of pIN-JHE811 reveals internalization signals in the Kv1.4 carboxy terminus. HEK293 cells transiently transfected 
with pIN-G (panels C and D), pIN-JHE811 (panels E and F), pIN-TGN (panels G and H), pIN-JHE811 L-A (panels I and J) and 
pIN-JHE811 Y-F (panels K and L) and were labeled with anti-HA antibodies and either fixed directly (panels C, E, G, I and K) or 
incubated for 1 hour at 37°C to allow antibody internalization (panels D, F, H, J and L). Internalized antibody was then detected 
using Cy3-conjugated 2° goat anti-mouse antibody. Green denotes PIN-protein fluorescence while red corresponds to the 
anti-HA antibody. Areas of red/green overlap are shown in yellow. Blue indicates DAPI-stained nuclei. Scale Bar: 15 µM.
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pIN-B were then digested with Pvu I, ligated to give a 1383
bp fragment which was then cloned into the correspond-
ing Snab I and Kpn I sites in pIN-G' to yield a correctly-
framed pIN-G product (5042 bp) containing a novel Pvu
I site.
pIN-TGN-38 vector construction
The pIN-TGN-38 construct, was generated by PCR ampli-
fication of the sequence encoding the trans-Golgi-Net-
work targeting signal (SEQYDRL: refs [13,14]) using
p∆Mep4-TGN-38-GFP as a template and the following
forward and reverse oligonucleotide primers: 5'-AGA AGC
CAC GTT CGC ACA ACA AAC G-3' and 5'-GAT CCC GGG
CCC GCG TCA AAG CTT TAG G-3' that contained 15 bp
homology to bases corresponding to the Kpn I site of pIN-
G. The resulting PCR fragment was then cloned into the
Kpn I site in the intracellular multiple cloning site (MCS-
2; see Fig. 1B) of pIN-G by homologous recombination
(BD-Dry Down In-Fusion PCR kit, Becton-Dickinson,
UK).
pIN-JHE811 vector construction
A pIN fusion construct, encoding pIN-G fused to the
entire intracellular carboxy terminus of the Kv1.4 voltage-
gated potassium channel, was generated by PCR using
pEYFP-Kv1.4 [15] as a template and the following forward
and reverse oligonucleotide primers: 5'-AAG TCT CTC
TCG GGC TTC AGC -3' and 5'- AAG TCT CTC TCG GGC
TTC AGC -3' that contained flanking sequences corre-
sponding to the Kpn I site of pIN-G. The resulting PCR
fragment was then cloned into the Kpn I site in MCS-2
and ligated using T4 ligase as described [15]. pIN-JHE811-
L-A and pIN-JHE811-Y-F were created using the Strata-
gene QuikChange site-directed mutagenesis kit with pIN-
JHE811 as a template and the following mutagenic oligo-
nucleotide primers: 5'-CA TAC CTA CCT TCT AAT TTG
CTC AAG AAA TTT CGG AGC TCT AC -3' and 5'-CTG
GGG GAC AAG TCA GAG TTT CTA GAG ATG GAA GAA
GGG-3'. The identity of all constructs was confirmed by
restriction mapping and DNA sequencing (ACGT,
Toronto, Canada, Geneblitz, Sunderland, UK).
Tissue culture
HEK293 cells were subcultured every 3–4 days, incubated
at 37°C in a humidified incubator and maintained with
5% CO2. Cells were detached from the flasks with phos-
phate-buffered saline without calcium and magnesium
(PBS-), quenched in fresh medium, and re-seeded into
T75 cm2 flasks. Cells were cultured in Dulbecco's minimal
essential medium (DMEM) containing 0.11 g/L sodium
pyruvate and pyridoxine and supplemented with 10% FBS
(v/v), 2 mM L-glutamine (w/v) and 1% penicillin and
streptomycin.
Transfection
All transfections were carried out using Fugene 6 (Roche,
UK), according to the manufacturers' instructions.
HEK293 cells were seeded at 1:40 from a confluent T75
into a 6-well plate and grown to 50% confluency over-
night at 37°C. 2 µg cDNA was added to 150 µl DMEM and
mixed in an eppendorf tube containing 6 µl of Fugene6
reagent and 150 µl DMEM. The cDNA and reagent solu-
tions were combined to allow the formation of lipid com-
plexes for 20 minutes at room temperature. Subsequent to
the addition of fresh DMEM, to remove any antibiotics,
the DNA-lipid complexes were added to the cells in a drop
wise manner and incubated for 12 hours at 37°C. After
this period cells were either transferred to a 10 cm dish for
further propagation or re-seeded 1:4 onto collagen-coated
coverslips in 12-well plates then incubated at 37°C over-
night.
Immunoblotting
HEK293 cells were lysed in RIPA buffer containing a cock-
tail of protease inhibitors (Roche, UK), and passed 8X
through a 22-gauge needle to shear nucleic acids. The
sheared lysate was then centrifuged at 16,000 gav for 15'
and aliquots of the supernatant electrophoresed, and
transferred to nitrocellulose and processed as described
previously [15] using monoclonal antibodies to HA
(1:1000)), or polyclonal antibodies to GFP (1:10,000).
Immunoreactivity was detected by incubating each mem-
brane with horseradish peroxidase-conjugated donkey
anti-mouse or anti-rabbit (1:1000; Amersham, UK) fol-
lowed by enhanced chemiluminescence (ECL; Amersham
Biosciences) and film detection (Amersham Bio-Max).
Immunostaining of transfected HEK293 cells
Image-based detection of PIN-fusion proteins was
observed in HEK293 cells transiently transfected with
pIN-G, pIN-TGN or pIN-JHE811, fixed in 4% paraformal-
dehyde for 20 minutes at room temperature, washed in
PBS, quenched with 0.1 M glycine and mounted onto
glass slides using ProLong Gold anti-fade (Molecular
Probes). The surface expression of PIN proteins was deter-
mined by incubating non-permeabilised, fixed cells with
anti-HA antibodies (1:1000) for 30 minutes at room tem-
perature and detecting with Cy3-conjugated goat anti-
mouse secondary antibody (1:200, Jackson Immunore-
search, Stratech Scientific, Cambs, UK). Intracellular stain-
ing of organelles was performed by fixing HEK293 cells in
4% paraformaldehyde (as above), permeabilising with
0.5% saponin for 5 minutes followed by incubation with
antibodies raised against the appropriate markers at a con-
centration of 10 µg/ml in 0.01% saponin. Detection of
specific staining was performed with Cy3-conjugated anti-
mouse secondary at 1:200.BMC Biotechnology 2006, 6:15 http://www.biomedcentral.com/1472-6750/6/15
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Internalization assays
Internalization of the PIN fusion proteins was determined
by pulse-labeling transfected HEK293 cells at 4°C with
anti-HA antibodies (1:1000) for 30 minutes. The cells
were then either fixed directly using 4% paraformalde-
hyde and permeabilised with 0.5% saponin, or incubated
for 1 hr at 37°C in fresh medium prior to fixation and per-
meabilisation. For imaging, internalized anti-HA anti-
body was detected with Cy3-conjugated goat anti-mouse
secondary (1:200) and nuclei were DAPI-stained (0.05
µg/ml) prior to mounting. For FACS analysis, to distin-
guish surface labeling transfected cells were not permeabi-
lised and external anti-HA antibody was detected with
Cy5-conjugated goat anti-mouse secondary (1:200)
Fluorescent activated cell sorting (FACS)
For surface analysis, transfected cells were detached with
PBS without calcium and magnesium (PBS-) and adjusted
to a concentration of 5 × 107/ml with DMEM containing
1% FBS (v/v). 100 µl aliquots of cells were incubated with
primary antibody (anti-HA) at a concentration of 10 µg/
ml diluted in Dulbecco's phosphate-buffered saline with
calcium and magnesium (PBS+) for 30 minutes at 4°C.
For pulse-chase assays, transfected cells were plated onto
10 cm cell-culture dishes and incubated overnight at
37°C. The dishes were placed on ice and the cells labeled
with anti-HA at a concentration of 10 µg/ml diluted in
PBS+ for 30 minutes at 4°C. Cells were then detached and
transferred to FACS tubes. After three washes with 300 µl
PBS+, 1% FBS (v/v), all samples were incubated with Cy5-
conjugated goat secondary anti-mouse IgG1  (1:200)
diluted in 10% FBS and 90% PBS+ (v/v) for 45 minutes at
4°C. Cells were fixed with 100 µl aliquots of 2% (w/v) for-
maldehyde, 100 µl PBS-, 300 µl PBS+. The dilutions of
antibodies used were saturating as confirmed by titration.
Cells (20,000 per sample) were analysed in a FACScaliber®
flow cytometer (Becton Dickinson, UK) and mean fluo-
rescent intensity values taken. Internalization half-lives
were determined assuming a first-order exponential.
Delta Vision deconvolution microscopy
Mounted coverslips were visualized on an Olympus IX-70
inverted microscope using a ×100 UPLAN objective (NA
1.35) and images captured on a Photometrics CH350L
CCD camera. The Delta Vision restoration microscope
(Applied Precision Instruments, Seattle) utilized a Unix-
based computer system equipped with SoftWoRx version
2.50, acquisition software. Epifluorescence was recorded
using filter sets for DAPI/FITC/Texas red and cy3/cy5.
Using the high precision nanochassis stage, widefield
optical sections of 0.2 µm were acquired throughout the z
plane of the cells. Z stacks generated were then decon-
volved using a constrained iterative algorithm assigned by
Delta Vision.
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